<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Cosmo Bio USA Inc. for $32,936.00 on August 22, 2019. Work is performed in Carlsbad, California. The order is priced on a firm fixed price basis with an ultimate completion date of February 24, 2020. The originating pre-solicitation opportunity was posted July 28, 2019 with an August 6, 2019 due date.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Becton, Dickinson and Company for $50,267.46 on July 8, 2026. Performance is located in Franklin Lakes, New Jersey. The order procures immunophenotyping and cellular analysis services using flow cytometry to support intramural research across multiple NIDDK projects. The purchase order is firm fixed price with no small business set-aside. Ultimate completion is July 7, 2027.</p>
<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Bioivt, LLC for $15,000.00 on September 8, 2020, for male human cryoplateable hepatocytes (5 million, Lot BGW, from reserve stock). Performance occurs in Westbury, New York. The order is firm fixed price with an ultimate completion date of October 8, 2020.</p>
The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $10,848.60 firm fixed-price purchase order contract to Life Technologies Corporation of Grand Island, New York. As the prime contractor, Life Technologies Corporation will provide unspecified products or services to the agency between March 15, 2019 and April 14, 2019 to support the National Institute of Diabetes and Digestive and Kidney...
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $24,545.41 on August 10, 2016. The order procures various laboratory equipment on a firm fixed price basis. Place of performance is Carlsbad, California. The order is scheduled for completion by September 30, 2016.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Research and Diagnostic Systems, Inc. for $11,681.56 on March 3, 2017. The order was firm fixed price with no set-aside. Performance occurred in Minneapolis, Minnesota. The order expired on May 31, 2017 and procured biological research materials and laboratory supplies, including proteins, antibodies, and assay kits for biomedical research support.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Vanderbilt University for $15,799.25 on June 5, 2020, for animal testing, with completion by September 10, 2020. Performance occurs at Bethesda, Maryland. The order carries firm fixed-price pricing and no set-aside designation.</p>
The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Information Management Services, Inc. for Biospecimen Inventory (BSI) License Subscription Support with a ceiling value of $102,772.00 on September 22, 2023. The order is firm fixed price and severable, with ultimate completion on September 21, 2028. Work is performed in Calverton, Maryland. The procurement originated from a Woman-Owned Small Business set-aside pre-solicitation posted May 12, 2023,...
<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a $37,343.66 delivery order to Illumina, Inc. on July 10, 2026.</p>
<p>Place of performance is Bethesda, MD 20892. No set-aside was used for this order. The order is priced on a firm fixed-price basis with an ultimate completion date of July 10, 2026.</p>